Insider Selling: Globe Life (NYSE:GL) CEO Sells 10,000 Shares of Stock

by · The Markets Daily

Globe Life Inc. (NYSE:GLGet Free Report) CEO Frank Svoboda sold 10,000 shares of the business’s stock in a transaction that occurred on Friday, June 12th. The stock was sold at an average price of $166.68, for a total transaction of $1,666,800.00. Following the transaction, the chief executive officer owned 54,020 shares of the company’s stock, valued at $9,004,053.60. This trade represents a 15.62% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Globe Life Stock Up 1.5%

Shares of Globe Life stock traded up $2.45 during trading hours on Monday, hitting $169.21. The company had a trading volume of 206,975 shares, compared to its average volume of 517,869. The company’s 50-day moving average is $152.88 and its two-hundred day moving average is $144.60. Globe Life Inc. has a twelve month low of $116.73 and a twelve month high of $169.50. The company has a debt-to-equity ratio of 0.38, a current ratio of 0.07 and a quick ratio of 0.07. The company has a market cap of $13.14 billion, a P/E ratio of 11.71 and a beta of 0.49.

Globe Life (NYSE:GLGet Free Report) last issued its earnings results on Wednesday, April 22nd. The company reported $3.43 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.46 by ($0.03). Globe Life had a net margin of 19.38% and a return on equity of 20.94%. The company had revenue of $1.56 billion during the quarter, compared to analyst estimates of $1.56 billion. During the same quarter in the previous year, the company posted $3.07 EPS. The company’s quarterly revenue was up 5.3% on a year-over-year basis. Globe Life has set its FY 2026 guidance at 15.400-15.90 EPS. Analysts anticipate that Globe Life Inc. will post 15.64 earnings per share for the current fiscal year.

Globe Life Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Monday, July 6th will be issued a $0.33 dividend. The ex-dividend date is Monday, July 6th. This represents a $1.32 annualized dividend and a dividend yield of 0.8%. Globe Life’s dividend payout ratio is presently 9.13%.

Institutional Trading of Globe Life

Several institutional investors and hedge funds have recently bought and sold shares of the business. Parallel Advisors LLC raised its position in Globe Life by 6.4% in the 1st quarter. Parallel Advisors LLC now owns 1,756 shares of the company’s stock valued at $244,000 after purchasing an additional 105 shares during the last quarter. Glenmede Trust Co. NA raised its position in Globe Life by 5.8% in the 1st quarter. Glenmede Trust Co. NA now owns 7,396 shares of the company’s stock valued at $1,029,000 after purchasing an additional 406 shares during the last quarter. Groupama Asset Managment purchased a new stake in Globe Life in the 1st quarter valued at $466,000. Edgestream Partners L.P. purchased a new stake in Globe Life in the 1st quarter valued at $7,513,000. Finally, Bull Harbor Capital LLC purchased a new stake in Globe Life in the 1st quarter valued at $538,000. Hedge funds and other institutional investors own 81.61% of the company’s stock.

Analysts Set New Price Targets

GL has been the subject of several research analyst reports. Piper Sandler upped their target price on shares of Globe Life from $167.00 to $175.00 and gave the company an “overweight” rating in a report on Tuesday, May 26th. Weiss Ratings upgraded shares of Globe Life from a “buy (b-)” rating to a “buy (b)” rating in a report on Wednesday, May 13th. Keefe, Bruyette & Woods restated a “moderate buy” rating and issued a $168.00 target price on shares of Globe Life in a report on Thursday, March 26th. Evercore set a $157.00 target price on shares of Globe Life in a report on Wednesday, February 18th. Finally, Texas Capital upgraded shares of Globe Life to a “strong-buy” rating in a research report on Wednesday, March 18th. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $174.11.

Read Our Latest Report on Globe Life

Globe Life Company Profile

(Get Free Report)

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.

Read More